A 48-year-old woman presents with progressive proximal muscle weakness and a violaceous rash affecting her upper eyelids with periorbital edema, along with flat-topped violaceous papules over the knuckles. The structure marked **A** in the diagram represents these pathognomonic skin findings. Which of the following best describes the underlying pathophysiologic mechanism distinguishing dermatomyositis from polymyositis?

Question

Accepted Answer

D. Humoral/complement-mediated microangiopathy with MAC deposition in endomysial capillaries causing capillary dropout and perifascicular atrophy. ## Why humoral/complement-mediated microangiopathy is right

Dermatomyositis is fundamentally distinguished from polymyositis by its pathogenic mechanism: complement-mediated microangiopathy. MAC (membrane attack complex C5b-9) deposits in endomysial capillaries, leading to capillary dropout, ischemia, and perifascicular muscle atrophy. This humoral/antibody-driven pathology directly correlates with the characteristic skin manifestations marked **A** (heliotrope rash and Gottron papules), which reflect the systemic nature of the complement-mediated vasculitis. The presence of these pathognomonic skin findings is the clinical hallmark that distinguishes DM from polymyositis, and both correlate with the same underlying complement-mediated mechanism.

## Why each distractor is wrong

- **T-cell mediated direct cytotoxic destruction**: This is the pathogenic mechanism of polymyositis, NOT dermatomyositis. Polymyositis lacks the characteristic skin findings marked **A** and does not show MAC deposition in capillaries.
- **Autoantibody-mediated blockade of the neuromuscular junction**: This describes myasthenia gravis, not dermatomyositis. DM does not involve NMJ pathology; it is a myopathy, not a neuromuscular transmission disorder.
- **Mitochondrial dysfunction with impaired oxidative phosphorylation**: This is the mechanism of mitochondrial myopathies (e.g., MELAS, MERRF), not inflammatory myopathies. DM is an acquired autoimmune condition, not a primary mitochondrial disorder.

**High-Yield:** Dermatomyositis = complement-mediated microangiopathy (humoral); Polymyositis = T-cell mediated (cellular). The skin findings of DM (heliotrope rash, Gottron papules) are the clinical signature of this complement-driven systemic vasculitis.

[cite: Harrison's 21e Ch 370; Bolognia 5e Ch 42]

Answer

A. T-cell mediated direct cytotoxic destruction of muscle fibers with CD8+ infiltration

Answer

B. Mitochondrial dysfunction with impaired oxidative phosphorylation in muscle cells

Answer

C. Autoantibody-mediated blockade of the neuromuscular junction

Explanation

Why humoral/complement-mediated microangiopathy is right

Why each distractor is wrong

Practice similar questions